The nurse’s role in preventing and diminishing side effects after chemotherapy

Authors

  • Marzena Kamińska Clinical Oncology Ward, St. John’s Cancer Center, Lublin, Poland Author
  • Tomasz Ciszewski Clinical Oncology Ward, St. John’s Cancer Center, Lublin, Poland Author
  • Agnieszka Bronikowska Clinical Oncology Ward, St. John’s Cancer Center, Lublin, Poland Author
  • Maria Ferańska Clinical Oncology Ward, St. John’s Cancer Center, Lublin, Poland Author
  • Agnieszka Pawlak-Warszawska Clinical Oncology Ward, St. John’s Cancer Center, Lublin, Poland Author
  • Elżbieta Starosławska Clinical Oncology Ward, St. John’s Cancer Center, Lublin, Poland Author

DOI:

https://doi.org/10.12923/j.0044-2011/123-4/a.13

Keywords:

cancer, chemotherapy, side effects

Abstract

Chemotherapy is one of the basic methods of cancer treatment. The methods of treatment used in oncology have recognized therapeutic value, but each of them is related to the possibility of side effects.
Ensuring the effectiveness and safety of the use of anticancer drugs as well as prevention of symptoms occurring as side effects is a fundamental principle of the treatment team.Careful monitoring of the course of treatment can significantly reduce the incidence of side effects.

References

1. Smith LA, Cornelius VR, Plummer CJ, et al. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer. 2010;10:337.

2. Sprauten M, Darrah TH, Peterson DR, et al. Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer. J Clin Oncol. 2012;30(3):300-7.

3. Kuebler JP, Colangelo L, O’Connell MJ, et al. Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a pro¬spective analysis. Cancer. 2007;110(9):1945-50.

4. Schaapveld M, Visser O, Louwman MJ, et al. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol. 2008;26(8):1239-46.

5. Fernández-Ortega P, Caloto MT, Chirveches E, Marquilles R, Francisco JS, Quesada A, Suárez C, Zorrilla I, Gómez J, Zabaleta P, Nocea G, Llombart-Cussac A. Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients’ quality of life. Support Care Cancer. 2012 Dec;20(12):3141-3148.

6. Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH, American Society of Clinical Oncology. Antiemetics: American Society of Clinical Oncology clinical prac¬tice guideline update. J Clin Oncol. 2011;29(31): 4189-4198.

7. Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D, ESMO/MASCC Guidelines Working Group. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol. 2010;21(Suppl. 5):v232-43.

8. Vidall C, Dielenseger P, Farrell C, et al. Evidence-based management of chemotherapy-induced nausea and vomiting: a position statement from a European cancer nursing forum. Ecancer med scien. 2011;5:211.

9. Hawkins R, Grunberg S. Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes. Clin J Oncol Nurs. 2009;13(1):54-64.

10. Avrischer EB, Cooksley cd, Elting LS. Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis. Semin Oncol Nurs. 2004;20(1):3-10.

11. Aksoy DY, Tanriover MD, Uzun O, Zarakolu P, Ercis S, Ergüven S, Oto A, Kerimoglu U, Hayran M, Abbasoglu O. Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis. Ann Oncol. 2007;18(1):183.

12. Smith L. Intestinal failure and the ward nurses: causes, assessment and management. Br J Nurs. 2012;21(6):S10-2, S14-5.

13. Andrews A, Morgan G. Constipation management in palliative care: treatments and the potential of independent nurse prescribing. Int J Pal¬liat Nurs. 2012;18(1):17-22.

14. Epstein JB, Thariat J, Bensadoun RJ, et al. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 2012;62(6):400-22.

15. Rubenstein EB, Peterson DE, Schubert M, et al. Mucositis Study Section of the Multinational Association for Supportive Care in Cancer: International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy – induced oral and gastrointestinal mucositis. Cancer. 2004;100(9 Suppl.):2026-46.

16. Barasch A, Peterson DE. Risk faktors for ulcerative oral mucositis in cancer patients: unanswered questions. oral Oncol. 2003:39:91-100.

17. 17. Sieracki RL, Voelz LM, Johannik TM, et al. Development and implementation of an oral care protocol for patients with cancer. Clin J Oncol Nurs. 2009;13(6):718-22.

18. 18. Papas AS, Clark RE, Martuscelli G, et al. A prospective, ran¬domized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003;31(8):705-12.

19. Miller M, Taylor A, Kearney N, et al. Evaluation of the feasibility and acceptability of an oral care diary by patients during chemotherapy. Int J Nurs Stud. 2007;44(5):693-701.

20. Green DM, Kawashima T, Stovall M, et al. Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2010;28(2):332-9.

21. Green DM, Kawashima T, Stovall M, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009;27(16):2677-85.

22. Barton SE, Najita JS, Ginsburg ES, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013;14(9):873-81.

23. Borsellino M, Young MM. Anticipatory coping: taking control of hair loss. Clin J Oncol Nurs. 2011;15(3):311-5.

24. Hilton S, Hunt K, Emslie C, et al. Have men been overlooked? A comparison of young men and women’s experiences of chemotherapy-induced alopecia. Psychooncol. 2008;17(6):577-83.

25. Perez Fidalgo JA, Garcia Fabregat L, Cervantes A, et al. Management of chemotherapy extravasation: ESMO-EONS Clinical Practice Guidelines. Ann Oncol. 2012;23(7 Suppl.):vii167-173.

26. Schulmeister L. Extravasation management: clinical update. Semin Oncol Nurs. 2011;27(1):82-90.

27. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56-93.

28. Flowers CR, Seidenfeld J, Bow EJ, Karten C, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31(6):794-810.

29. de Naurois J, Novitzky-Basso I, Gill MJ, et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21(Suppl. 5):v252-6.

30. Coughlan M, Healy C. Nursing care, education and support for patients with neutropenia. Nurs Stand. 2008;22(46):35-41.

31. Moore K, Fortner B. Utility of routine nurse assessment of the risk of chemotherapy-induced febrile neutropenia. Can Oncol Nurs J. 2010;20(2):75-9.

32. Rodgers GM 3rd, Becker PS, Bennett CL, et al. Cancer and chemotherapy-induced anemia. J Natl Compr Canc Netw. 2008;6(6):536-64.

33. Merlini L, Cartenì G, Iacobelli S, et al. Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy. Cancer Manag Res. 2013;5:205-14.

34. Thiagarajan P, Afshar-Kharghan V. Platelet transfusion therapy. Hematol Oncol Clin North Am. 2013;27(3):629-43.

35. Kuter DJ. New thrombopoietic growth factors. Blood. 2007;109(11):4607-16.

36. Damron BH, Brant JM, Belansky HB, et al. Putting evidence into practice: prevention and management of bleeding in patients with cancer. Clin J Oncol Nurs. 2009;13(5):573-83.

37. Pagano L, Pulsoni A, Mele L, et al. Acute myeloid leukemia in patients previously diagnosed with breast cancer: Experience of the Gimema group. Ann Oncol. 2001:12:203-7.

38. Seidman A, Hudis C, Pierri MK. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin. Oncol. 2002:20:1215-21.

Zdrowie Publiczne 2013, Vol.123, N 4

Downloads

Published

2013-12-01

Issue

Vol. 123 No. 4 (2013): Zdrowie Publiczne

Section

Artykuły